相关实验视频

Updated: Jun 19, 2025

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
08:04

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

11.7K

在患有晚期胸腺癌的患者免疫抵抗后,重新挑战免疫疗法

Keda Shao1,2, Xiaohong Zeng1,2, Yue Hao2

  • 1Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|July 24, 2024
PubMed
概括

挑战性免疫疗法在先进的胸膜癌 (TC) 患者中显示出有限的有效性,这些患者对初始治疗有抗性. 与化疗相比,这种方法导致了较低的反应率和较短的无进展生存期.

关键词:
免疫治疗是一种免疫疗法.再次挑战 挑战电阻 电阻 电阻 电阻 电阻 电阻胸腺癌 (thymic carcinoma) 是一种癌症.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.0K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
68.0K